Summary
The hexachlorophene-induced cytotoxic brain oedema is used as experimental model of brain damage, suitable for testing cerebroprotective substances. It has clinical importance since many brain injuries are accompanied by an oedema. The primary target of the neurotoxin, hexachlorophene, is the neuronal cell membrane, but it also causes secondary effects including a disruption of myelin lamellae, increases in water and sodium content, decreases of potassium content, and vacuolation in the white matter. Rats received orally hexachlorophene 240 mg/kg a day for three weeks by liquid diet. The disruption of coordinative motor response, observed in a specially developed test, was used to characterise hexachlorophene-induced injuries in studies designed to evaluate the potential of cerebroprotective substances. Because of their membranotropic efficacy some nootropic substances with different modes of action were examined. The disturbance of coordinative motor response was restored significantly earlier than in spontaneous remission following administration of piracetam, pyritinol, methyl glucamine orotate, naftidrofuryl, and also under the influence of the calcium antagonists cinnarizine, flunarizine and nifedipine. These results support the therapeutic use of nootropic substances in the management of neurotoxic injuries and brain oedema.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andreas K (1989) Effects of acute and chronic ethanol administration on synaptic processes and pharmacotherapeutic possibilities for the treatment of alcoholism. Biogenic Amines 6:201–231
Andreas K (1991) Cytotoxic brain oedema as a model in the examination of cerebroprotective substances. Arch Toxicol [Suppl] 14:25–29
Bunge RP (1968) Glial cells and the central myelin sheath. Physiol Rev 48:197–231
De Robertis E (1960) Some observations on the ultrastructure and morphogenesis of photoreceptor. J General Physiol 43 [Suppl 2]:1–4
Gump WS (1969) Toxicological properties of hexachlorophene. J Soc Cosmetic Chemists 20:173–179
Fischer HD, Wustmann Ch, Schmidt J (1984) On some mechanisms of antihypoxic actions of nootropic drugs. Biomed Biochim Acta 43:451–543
Haustein KO (1985) Kardiovaskuläres System. In: Markwardt F, Matthies H, Oelßner W (eds) Medizinische Pharmakologie. Thieme, Leipzig, pp 527–528
Hoffman PL, Rabe CS, Grant KA, Valverius P, Hundspith M, Tabakoff B (1990) Ethanol and the NMDA receptor. Alcohol 7:229–231
Kemski O, Gross U, Baethmann A (1982) An in vitro model of cytotoxic brain edema: Cell volume and metabolism of cultivated glial- and nerve-cells. Adv Neurosurg 10:254–258
Kimbrough RD, Gaines TB (1971) Heachlorophene effects on the rat brain: study of high doses by light and electron microscopy. Arch Environ Health 23:114–120
Klatzo I (1967) Presidential address: Neuropathological aspects of brain oedema. J Neuropathol Exp Neurol 26:1–14
Krieglstein J (1990) Hirnleistungsstörungen: Pharmakologie und Ansätze für die Therapie. Wiss. Verl.-Ges., Stuttgart, pp 50–55
Lampert P, O'Brien J, Garret R (1973) Hexachlorophene encephalopathia. Acta Neuropathol 23:326–335
Matthis H (1985) Zentralnervensystem. In: Markwardt F, Matthies H, Oelßner W (eds) Medizinische Pharmakologie. Thieme, Leipzig, pp 253–254
Rezvani AH, Mack CM, Delcy PA, Janowsky DS (1990) Verapamil effects on physiological and behavioural responses to ethanol in the rat. Alcohol Alcohol 25:51–58
Robertson JD (1955) The ultrastructure of adult vertebrate peripheral myelinated nerve fibers in relation to myelinogenesis. J Biophys Biochem Cytol 1:271–277
Sampaolo S, Nakagawa Y, Jannotti F, Cervos-Navarro I, Bonavita V (1991) Blood-brain barrier permeability to micromolecules and edema formation in the early phase of incomplete continuous ischemia. Acta Neuropathol 82:107–111
Schmidt J (1982) Zur Pharmakologie der Nootropika. In: Oehme P, Löwe H, Gores E (eds) Beiträge zur Wirkstofforschung, Vol 17. Akademie-Industrie-Komplex Arzneimittelforschung, Berlin, pp 1–175
Towfighi I (1980) Hexachlorophene. In: Spencer PS, Schaumburg HH (eds) Experimental and clinical neurotoxicology. Williams and Wilkins, Baltimore London, pp 440–455
Towfighi I, Gonates NK, Mc Cree L (1974) Hexachlorophene-induced changes in central and peripheral myelinated axons of developing and adult rats. Lab Invest 31:712–717
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andreas, K. Efficacy of cerebroprotective substances in the management of functional disorders induced by the cytotoxic brain oedema-producing substance hexachlorophene. Naunyn-Schmiedeberg's Arch Pharmacol 347, 79–83 (1993). https://doi.org/10.1007/BF00168776
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00168776